Big Rock Partners Acquisition News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.02.22	Pre-market Movers: BON, FB, BPTS, LSPD, SNAP… (RTTNews)
03.02.22	NRx Pharmaceuticals Announces Closing of $25 Million Private Placement Priced at a Premium to Market Under Nasdaq Rules (PR Newswire)
31.01.22	NRx Pharmaceuticals Announces $25 Million Private Placement Priced at a Premium to Market under Nasdaq Rules (PR Newswire)
27.01.22	NRx Announces Publication of Initial Findings of BriLife® Vaccine-produced Antibodies Against Omicron Variant (PR Newswire)
26.01.22	NRx Pharmaceuticals Gets First Safety Report For Its Covid-19 Drug From A Southwestern Hospital (RTTNews)
26.01.22	NRx Receives Initial Report of Patient Safety and Survival from Right to Try use of ZYESAMI® (aviptadil) during Omicron Surge (PR Newswire)
12.01.22	NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics (PR Newswire)
05.01.22	NRx Seeks Emergency Approval For ZYESAMI To Treat Patients At Immediate Risk Of Death From COVID-19 (RTTNews)
05.01.22	NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug Administration for ZYESAMI® (aviptadil) to Treat Patients at Immediate Risk of Death from COVID-19 Despite T... (PR Newswire)
03.01.22	NRx Files Provisional Patent For Stable Compositions Of Aviptadil Suitable For Human Use (RTTNews)
03.01.22	NRx Pharmaceuticals Files Provisional Patent for Stable Compositions of Aviptadil Suitable for Human Use (PR Newswire)
29.12.21	NRx Pharma Files Breakthrough Therapy Designation Request For ZYESAMI (RTTNews)
29.12.21	NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approve... (PR Newswire)
22.11.21	Pre-market Movers: ASTR, VG, CEI, CMBM, PTNR… (RTTNews)
05.11.21	NRx Pharmaceuticals Initiates Senior Level Finance and Business Initiatives with Luxembourg Ministry of the Economy, BNP Paribas, and Vaccine Manufacturing Partners for BriLife® COVID-19 Vaccine P... (PR Newswire)
05.11.21	Pre-market Movers: RWLK, OTRK, EVAX, NRXP, PTON… (RTTNews)
04.11.21	US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure (PR Newswire)
03.11.21	Pre-market Movers: BBBY, RRD, GKOS, TMBR, IRTC… (RTTNews)
02.11.21	NRx Pharmaceuticals Announces Favorable, New Safety Report for ZYESAMI® (aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19 (PR Newswire)
14.10.21	Journal of Infectious Diseases and Treatment Publishes Positive Trial Data of Aviptadil in High Comorbidity Patients Suffering from Critical COVID-19 with Respiratory Failure (PR Newswire)
13.10.21	Pre-market Movers: WTRH, NEW, RGLS, KOSS, PROC… (RTTNews)
12.10.21	NRx Pharmaceuticals Announces Progress on Worldwide Commercial Scale Development of ZYESAMI™ (aviptadil) (PR Newswire)
07.10.21	Pre-market Movers: CYRN, CEI, OSMT, NURO, TTM… (RTTNews)
29.09.21	NRx Pharma: Data Safety Monitoring Board Finds No New Safety Concerns In ACTIV-3b Trial (RTTNews)
29.09.21	NRx Pharmaceuticals Announces Second Favorable Safety Report for ZYESAMI™ (aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19 (PR Newswire)
27.09.21	NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil) (PR Newswire)
08.09.21	NRx Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
07.09.21	Pre-market Movers: IRNT, MTL, IFRX, FWP, JAGX, IPHA… (RTTNews)
30.08.21	NRx : Zyesami Phase 2b/3 Trial Result Shows Relief From Respiratory Distress In Critical COVID-19 (RTTNews)
30.08.21	NRx Pharmaceuticals Announces New Finding from ZYESAMI™ (aviptadil) Phase 2b/3 Clinical Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19 (PR Newswire)
26.08.21	NRx Pharmaceuticals to Work with Cardinal Health to Ensure Efficient Distribution of Potential Therapies (PR Newswire)
24.08.21	NRx Pharmaceuticals Announces Closing of $30 Million Private Placement (PR Newswire)
23.08.21	Participants in High Dose BriLife™ Investigational Vaccine Trial for COVID-19 Advised Booster Not Necessary (PR Newswire)
19.08.21	NRx Pharmaceuticals Announces $30 Million Private Placement (PR Newswire)
18.08.21	NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) in NIH Sponsored ACTIV-3 Critical Care Study in Patients with Life-Threatening COVID-19 (PR Newswire)
17.08.21	NRx Pharmaceuticals Announces 2nd Quarter 2021 Financial Update (PR Newswire)
10.08.21	NRx Pharmaceuticals to Ring Nasdaq Closing Bell on August 10, 2021 (PR Newswire)
09.08.21	NRx Pharmaceuticals Announces Initiation of Phase 2b Trial of BriLife™ Vaccine for Covid-19 in Nation of Georgia (PR Newswire)
04.08.21	MannKind Partners With NRx Pharma To Explore Dry Powder Formulation Of ZYESAMI (RTTNews)
04.08.21	MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform (PR Newswire)
04.08.21	NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions (PR Newswire)
27.07.21	NRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia (PR Newswire)
22.07.21	NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI™ (aviptadil), Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory ... (PR Newswire)
19.07.21	NRx Pharmaceuticals Presents Evidence ZYESAMI™ (aviptadil) Helps Prevent "Cytokine Storm" in Patients with COVID-19 (PR Newswire)
12.07.21	NRx Pharmaceuticals Announces Partnership with the Israel Institute for Biological Research to Complete Development and Commercialization of BriLife™ COVID Vaccine (PR Newswire)
12.07.21	NRx Pharma, Quantum Leap Announce Inhaled ZYESAMIÔ Treatment For COVID-19 Patients (RTTNews)
12.07.21	NRx Pharmaceuticals and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with ZYESAMIÔ (Aviptadil) in the I-SPY COVID Trial (PR Newswire)
06.07.21	NRx Initiates Emergency Use Training And Extends Phase 2/3 Inhaled ZYESAMI Trial In Georgia (RTTNews)
06.07.21	NRx Pharmaceuticals Announces Initiation of Emergency Use Training and Extension of Phase 2/3 Inhaled ZYESAMI™ (Aviptadil-acetate) Trial in the Nation of Georgia (PR Newswire)
15.06.21	NRx Pharmaceuticals Announces Positive Data Results from ZYESAMI™ (Aviptadil) Expanded Access Protocol (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Big Rock Partners Acquisition Corp Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten